← Back to headlines
Nasdaq-Listed Biotechs Announce Stock-Based Inducement Grants
Several publicly traded biotechnology and healthcare companies have disclosed new equity awards designed to attract and retain key personnel. These filings comply with Nasdaq Listing Rule 5635(c)(4), which permits such inducement grants outside standard executive compensation plans.
2 Sept, 12:19 — 2 Sept, 21:00
The Story
Analyzing sources…
Source Diversity
Source Diversity
Low (24/100)2 sources— more sources would strengthen this score15/33
Spectrum spread— 1/5 buckets covered0/33
Far L
Left
Center2
Center (2)
taiwan-newsmorningstar
Right
Far R
Geographic diversity— 2 regions9/34
Taiwan1US1
ℹOnly 2 sources cover this story
Sources
Showing 2 of 2 sources
morningstar1d ago
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules - Morningstar
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules Morningstar
Read full article →taiwan-newsMostly Factual1d ago
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Taiwan News
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Taiwan News
Read full article →Coverage Timeline
First report: morningstar · 2 Sept, 12:19|Full coverage: 2 · 9h|Window: 9h
Left-leaningCenterRight-leaning
Related Stories
Japan Household Spending Falls for Eighth Consecutive Month
11m ago
US Investigates Deadly Strike on Iranian Wedding Linked to American Munition
16m ago
Yen Surges to 155 Against Dollar Amid Fed Rate Hold and BOJ Hike Speculation
26m ago
Volkswagen Approves Major Restructuring Plan to Cut 100,000 Jobs
1h ago